CSIMarket
 


Biotechnology & Pharmaceuticals Industry

Management Effectiveness Information & Trends 
 
Category:   Period:  

Biotechnology & Pharmaceuticals Industry 4 Q 3 Q 2 Q 1 Q 4 Q
  2023 2023 2023 2023 2022
Return On Assets (TTM) 2.18 % 2.29 % 4.54 % 5.86 % 5.39 %
Return On Assets Ranking # 75 # 70 # 49 # 42 # 40
Return On Investment (TTM) 2.71 % 2.86 % 5.67 % 7.29 % 6.73 %
Return On Investment Ranking # 77 # 70 # 51 # 45 # 43
Return On Equity (TTM) 6.63 % 6.62 % 12.6 % 16.03 % 14.05 %
Return On Equity Ranking # 81 # 79 # 57 # 49 # 55


Roa Comment

Biotechnology & Pharmaceuticals Industry yielded return on assets in 4 Q 2023 below Industry average at 2.18 %.

ROA fell from the previous period, due to detoriation of net income.
Within Healthcare sector 3 other industries have achieved higher return on assets. Return on assets total ranking has deteriorated in contrast to the previous peer from 70 to 75.

 
Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.

Return On Assets Statistics
High Average Low
226.6 % 14.81 % -0.96 %
1. quarter 2016   3. quarter 2019

Return On Assets Industry Ranking
Within: No.
Sector # 4
Overall # 75



Other ROA
Compare Industry's ROE to Ggr's or S&P Constituent list of Biotechnology & Pharmaceuticals Industry
Highest Ranking Return On Assets Lowest Ranking Return On Assets
Return On Assets for GGR's Competitors Definiton of Return On Assets


Biotechnology & Pharmaceuticals Industry Return On Investment Statistics

 

 

 
Return On Investment Statistics
High Average Low
34.54 % 8.61 % -1.29 %
4. quarter 2015   3. quarter 2019

Roi Comment
Biotechnology & Pharmaceuticals Industry achieved return on average invested assets of 2.71 % in 4 Q 2023, below Industry average return on investment.

ROI fell from the period before, due to detoriation of net income.

Within Healthcare sector 3 other industries have achieved higher return on investment. Return on investment total ranking was lower relative to the previous quarter from 70 to 77.

Return On Investment Industry Ranking
Within: No.
Sector # 4
Overall # 77
Other ROI
Compare Industry's ROI to Ggr's or S&P Constituent list of Biotechnology & Pharmaceuticals Industry
Highest Ranking Return On Investments Lowest Ranking Return On Investments
Return On Investments for GGR's Competitors Definiton of Return On Investments


Biotechnology & Pharmaceuticals Industry Return On Equity Statistics


 
Return On Equity Industry Ranking
Within: No.
Sector # 3
Overall # 81

Roe Comment
Biotechnology & Pharmaceuticals Industry returned in 4 Q 2023 6.63 % on shareholder's equity, below Industry average return on equity.

In spite of declining net income, IndustryROE has improved relative to the preceding period.

Within Healthcare sector 2 other industries have achieved higher return on equity. Return on equity total ranking has declined from the quarter ago, from 79 to 81.





Return On Equity Statistics
High Average Low
41.2 % 14.93 % -2.49 %
4. quarter 2015   3. quarter 2019

 
Other ROE
Compare Industry's Return On Equity to Ggr's or S&P Constituent list of Biotechnology & Pharmaceuticals Industry
Highest Ranking Return On Equity Lowest Ranking Return On Equity
Return On Equity for GGR's Competitors Definiton of Return On Equity






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com